Related Experiment Video
Updated: Oct 2, 2025

Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions
Anne-Sophie Donnet1, Syed Shariq Hasan2, Peter J Whorwell3
1Neurogastroenterology Unit, Wythenshawe Hospital, Manchester, UK.
Hypnotherapy (HT) effectively improved irritable bowel syndrome (IBS) symptoms and patient well-being. Patients reported significant additional benefits, even if initial expectations varied, highlighting the holistic impact of HT for IBS.
Area of Science:
- Gastroenterology
- Psychosomatic Medicine
- Complementary and Alternative Medicine
Background:
- Irritable bowel syndrome (IBS) is frequently treated with hypnotherapy (HT), with studies traditionally focusing on symptom severity.
- Emerging research highlights the importance of patient perception and expectations in treatment outcomes, which may diverge from healthcare provider assessments.
Purpose of the Study:
- To evaluate patient-reported perceptions and expectations of hypnotherapy (HT) in irritable bowel syndrome (IBS).
- To correlate patient expectations and perceptions with symptom response to HT in IBS patients.
Main Methods:
- 150 IBS patients underwent hypnotherapy (HT), completing validated questionnaires on symptom severity, quality of life, noncolonic symptoms, anxiety, and depression.
- Patient expectations and perceptions of HT were systematically recorded pre- and post-treatment, including qualitative free-text reflections.
Main Results:
- 81% of patients responded positively to HT, showing significant improvements in all measured parameters (p < 0.001).
- Higher initial expectations for improvement were noted in non-responders (63%) compared to responders (57%, p < 0.001).
- Despite initial skepticism, patients reported substantial additional benefits, with 70% of non-responders finding HT worthwhile.
Conclusions:
- Hypnotherapy (HT) offers significant symptom improvement and diverse additional benefits for irritable bowel syndrome (IBS) patients, often overcoming initial negative perceptions.
- Patient expectations did not directly correlate with treatment outcomes, underscoring the complexity of the therapeutic experience.
- Assessing IBS treatment efficacy solely through symptom severity overlooks the broader patient experience, necessitating the inclusion of patient-reported outcomes in future research.
More Related Videos
06:33Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...